Total raised
$84.2M
Last stage
Series B
Investors
Kévin Alessandri
Biophysicist; co-founded TreeFrog Therapeutics in 2018 in Bordeaux, France. Led the creation of the C-Stem technology platform and later relocated to Boston to head the US subsidiary.
LinkedInMaxime Feyeux
Stem cell biologist; co-founded TreeFrog Therapeutics in 2018. Previously a postdoc at Institut des Maladies Neurodégénératives and maturation engineer at Aquitaine Science Transfert.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.